A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma-Reference-Cited by-同舟云学术

A step forward on the in vitro and in vivo assessment of a novel nanomedicine against melanoma

Published:2023-06 Issue: Volume:640 Page:123011
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Pinho Jacinta O.^ORCID,Matias Mariana^ORCID,Godinho-Santos Ana,Amaral Joana D.,Mendes Eduarda,Perry Maria Jesus,Francisco Ana Paula,Rodrigues Cecília M.P.,Gaspar M. Manuela

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference80 articles.

1. Drug delivery systems: Entering the mainstream;Allen;Science,2004

2. Combined pitavastatin and dacarbazine treatment activates apoptosis and autophagy resulting in synergistic cytotoxicity in melanoma cells;Al-Qatati;Oncol. Lett.,2017

3. Synthesis of new pyrazole hybrids as potential anticancer agents with xanthine oxidase inhibitory activity;Alsayari;Anticancer. Agents Med. Chem.,2022

4. Design, synthesis, and molecular docking of paracyclophanyl-thiazole hybrids as novel CDK1 inhibitors and apoptosis inducing anti-melanoma agents;Aly;Molecules,2020

5. Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice;Avram;Oncol. Rep.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nano-mediated strategy: recent advance in the application of drug delivery systems in melanoma treatment and diagnosis;Biomedical Materials;2024-08-21

2. Necroptosis induced by ruthenium (II) complexes as mitochondrial disruptors;Cell Death Discovery;2024-05-28

3. An alternative hybrid lipid nanosystem combining cytotoxic and magnetic properties as a tool to potentiate antitumor effect of 5-fluorouracil;Life Sciences;2024-05

4. Liposomal Rifabutin—A Promising Antibiotic Repurposing Strategy against Methicillin-Resistant Staphylococcus aureus Infections;Pharmaceuticals;2024-04-08

5. New pyrazolylindolin-2-one based coumarin derivatives as anti-melanoma agents: design, synthesis, dual BRAF^V600E/VEGFR-2 inhibition, and computational studies;RSC Advances;2024